| Financial Year |
March 31 2023 |
| Monetary Funds |
1,624,822,021.56 |
| Held-for-trading Financial Assets |
37,989,137.56 |
| Notes Receivable |
107,751,450.25 |
| Accounts Receivable |
428,526,194.86 |
| Advances to Suppliers |
9,169,153.62 |
| Other Receivables |
878,694,809.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
99,782,013.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
71,042,688.70 |
| Total Current Assets |
3,258,078,472.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,556,800,596.35 |
| Investment Properties |
-- |
| Fixed Assetes |
9,782,645,902.24 |
| Under-construction Projects |
357,558,034.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
416,560,815.98 |
| R&D expenses |
-- |
| Goodwill |
23,850,505.65 |
| Long-Term Deferred and Prepaid Expenses |
8,641,545.95 |
| Deferred Income Tax Assets |
1,117,481.94 |
| Other Non-Current Assets |
13,177,151.19 |
| Sub-Total of Non-Current Assets |
12,214,022,423.01 |
| Total Assets |
15,472,100,895.10 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
34,800,000.00 |
| Accounts Payable |
694,109,849.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,096,489.02 |
| Taxes Payable |
113,909,494.82 |
| Interest Payable |
-- |
| Dividend Payable |
3,600,072.84 |
| Other payables |
914,737,352.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,162,071,879.78 |
| Other Current Liabilities |
523,772.76 |
| Sub-Total of Current Liabilities |
3,306,075,121.90 |
| Long-term Loans |
7,246,268,012.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
210,280,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
33,643,445.14 |
| Deferred Income Tax Liabilities |
194,438.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,268,150,916.29 |
| Total Liabilities |
11,574,226,038.19 |
| Paid-In Capital(Or Share Stock) |
370,050,484.00 |
| Capital Surplus |
2,541,841,681.18 |
| Surplus Reserve |
91,125,835.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
654,112,817.56 |
| Minority Stockholder's Interest |
232,577,126.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,665,297,729.92 |
| Owner's Equity（Stockholder's Equity） |
3,897,874,856.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,472,100,895.10 |
